Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Jonsson Comprehensive Cancer Center
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
Emory University
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
St. Jude Children's Research Hospital
Alliance for Clinical Trials in Oncology
University of Chicago
Dana-Farber Cancer Institute